Editorial Board Members’ Collection Series: Chitosan in Biomedicine: Current Status, Future Perspectives and Challenges

Dear Colleagues,

In recent decades, chitosan biomaterial, mainly in its nanostructure form, has gained extraordinary relevance in the biomedical field due to its unique biological properties. It is nontoxic, biodegradable, biocompatible, mucoadhesive and promotes mucosal drug absorption. In addition, it has antibacterial, antimicrobial, anti-inflammatory, antitumor, immunostimulatory and wound healing properties. For all these reasons, chitosan and its derivatives are having an enormous impact on the fields of drug delivery, gene therapy, vaccination, tissue engineering, regenerative medicine and wound dressing, among others. In their application, the use of chitosan-based starting materials that are well characterized is an urgent requirement, and the properties of chitosan derivatives are being continuously improved to ensure they are suitable for application.

This Special Issue focuses on the latest research advances on systems based on chitosan and its derivatives in biomedicine, including (but not limited to): (a) delivery of proteins, antibiotics, antigens and nucleic acids; (b) diagnosis and treatment of cancer (theranostics); and (c) applications in tissue engineering. The aim is to provide an updated status and perspectives on future research in the aforementioned topics and to emphasize the challenges for their translation to the clinic.

Original research articles and review manuscripts on the aforementioned topics are welcome.

Prof. Dr. Carmen Remuñán-López
Prof. Dr. Maria Bonferoni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.